Jeon S.J.,Seoul National University |
Jeon S.J.,Institute for Advanced Biomedical science |
Bak H.,Seoul National University |
Seo J.,Seoul National University |
And 13 more authors.
Biomolecules and Therapeutics | Year: 2012
Oroxylin A is a flavone isolated from a medicinal herb reported to be effective in reducing the inflammatory and oxidative stresses. It also modulates the production of brain derived neurotrophic factor (BDNF) in cortical neurons by the transactivation of cAMP response element-binding protein (CREB). As a neurotrophin, BDNF plays roles in neuronal development, differentiation, synaptogenesis, and neural protection from the harmful stimuli. Adenosine A2 A receptor colocalized with BDNF in brain and the functional interaction between A2 A receptor stimulation and BDNF action has been suggested. In this study, we investigated the possibility that oroxylin A modulates BDNF production in cortical neuron through the regulation of A2 A receptor system. As expected, CGS21680 (A2 A receptor agonist) induced BDNF expression and release, however, an antagonist, ZM241385, prevented oroxylin A-induced increase in BDNF production. Oroxylin A activated the PI3K-Akt-GSK-3β signaling pathway, which is inhibited by ZM241385 and the blockade of the signaling pathway abolished the increase in BDNF production. The physiological roles of oroxylin A-induced BDNF production were demonstrated by the increased neurite extension as well as synapse formation from neurons. Overall, oroxylin A might regulate BDNF production in cortical neuron through A2 A receptor stimulation, which promotes cellular survival, synapse formation and neurite extension. © 2012 The Korean Society of Applied Pharmacology. Source